companydata.dkcompanydata.dk

OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2022

CVR: 35532900

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,257 and a net result of DKK 29,664 compared with DKK 28,680 the year before. Equity in the 2022 report amounted to DKK 113,946. The solvency ratio was 96.1%.

Gross Profit
DKK -7,257
Profit/Loss
DKK 29,664
Equity
DKK 113,946
Total Assets
DKK 118,588

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--7K30K114K-
2021--7K29K109K-
2020--6K23K104K-
2019--6K22K108K-
2018--8K27K116K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on OLANDER CLINICAL CONSULTING 1 ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

OLANDER CLINICAL CONSULTING 1 ApS: The 2021 annual report is outJun 15, 2022

OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2021. Gross profit came to DKK -6,657, and the net result was DKK 28,680.

About OLANDER CLINICAL CONSULTING 1 ApS

OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity in the 2025 report amounted to DKK 167,137.

Source: annual report 2025, Danish Business Authority